Our 2024 program

Who are our participants?

Up to 100 participants are selected annually from across Australia. The program is suited to mid-career professionals looking to expand their commercialisation knowledge and networks, including:

  • researchers
  • scientists
  • entrepreneurs
  • legal practitioners (including IP and patents)
  • clinicians
  • venture capitalists
  • business development personnel
  • staff from regulatory and government agencies

A pharmaceutical or biotech background and a demonstrated interest in commercialisation is essential.

Applications 2024 are now closed.

Thank you to everyone who applied.

We will email you to let you know the outcome of your application in early Quarter 2.

More information